There is 1 paper on MRD-negativity in aging research: 1 trial in people.
1 paper studies it1 finding
See all 1 papers on MRD-negativity
“Attainment of MRD-negativity patients after induction and intensification chemotherapy was more common in PAX5alt, TCF3::PBX1 and ZNF384-R B-ALL”
- Human trial1
Associations
1PAX5alt, TCF3::PBX1 and ZNF384-R B-ALL
upin humans1
1 study
PAX5alt, TCF3::PBX1 and ZNF384-R B-ALL
upin humans1
PAX5alt, TCF3::PBX1 and ZNF384-R B-ALL is associated with MRD-negativity in humans after induction and intensification chemotherapy.
“Attainment of MRD-negativity patients after induction and intensification chemotherapy was more common in PAX5alt, TCF3::PBX1 and ZNF384-R B-ALL”
Human trialafter induction and intensification chemotherapy
Blood